Adamas Pharmaceuticals Inc (ADMS)

Trade ADMS now with
9/16/2021 9:22:43 AM Adamas Announces GOCOVRI Presentations At International Parkinson And Movement Disorder Society's Congress
7/22/2021 9:18:40 AM Adamas Pharma Announces Issuance Of New Patents For GOCOVRI And ADS-4101
6/10/2021 9:39:41 AM Adamas : Data Analysis Supports GOCOVRI As Treatment For Motor Complications For People With Parkinson's Disease
5/10/2021 4:06:44 PM Adamas Reports Q1 Loss Per Share Of $0.36 Vs. $0.59 Per Share Last Year
2/24/2021 9:25:02 PM Adamas Pharma Announces Pricing Of Follow-on Public Offering Of 12.50 Mln At $4.40/shr
2/1/2021 8:06:56 AM Adamas Enters Settlement Of Patent Litigation With Zydus
12/2/2020 6:51:50 AM Adamas Signs Agreement To Settle Its Ongoing Patent Litigation With Osmotica
9/11/2020 9:33:58 AM Adamas Presents New Post-hoc Data Analysis For GOCOVRI In Parkinson’s Disease Patients With Dyskinesia
8/25/2017 10:28:45 AM William Blair Reiterates Adamas Pharmaceuticals Inc (ADMS) At Ourperform